This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Innovations by Mu-En Lee in Gene Regulation
Introduction
Mu-En Lee is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of gene regulation, particularly in developing methods for cell-specific expression of genes. Her work is crucial for advancing therapies aimed at vascular and cardiovascular diseases.
Latest Patents
Mu-En Lee holds a patent for "Cell specific gene regulators." This invention provides methods and compositions for directing cell-specific expression of genes using the endothelin-1 promoter and its elements. The technology is designed to enhance the expression of heterologous genes specifically in endothelial cells, which is vital for targeted therapeutic applications.
Career Highlights
Mu-En Lee is affiliated with The General Hospital Corporation, where she continues to innovate in the field of gene therapy. Her research focuses on developing advanced techniques that can lead to more effective treatments for various cardiovascular conditions.
Collaborations
Mu-En Lee collaborates with Thomas Quertermous, a fellow researcher in her field. Their partnership aims to further explore the potential of gene regulation technologies in clinical applications.
Conclusion
Mu-En Lee's work in gene regulation exemplifies the innovative spirit of modern science. Her contributions are paving the way for new therapeutic strategies in treating cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile